← Leaderboards
Zibo Li
Univ Of North Carolina Chapel Hill
$7,321,417
Attributed
$13,460,320
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,460,320 · 9
By mechanism
R01$11,457,891 · 6
S10$834,500 · 1
P30$806,194 · 1
U54$361,735 · 1
Top collaborators
- Jin Xie9 shared
- Joseph M Fox6 shared
- Stergios Moschos5 shared
- David A Nicewicz5 shared
- William Y Kim4 shared
- Peter S Conti1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Charles M Perou$46,508,459
- Jun Lian$1,025,276
- Sha X Chang$2,472,824
- David A Nicewicz$7,623,720
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMalignant NeoplasmsPositron-Emission TomographyImageMolecular ImagingRadiotracerTumorLabelBaseSuccessCellsRadiochemistryClinical ResearchPharmaceutical PreparationsTreatment EfficacyLeadUniversitiesIn VitroPropertyAnalogRadiolabeledClinical TranslationTracerDiagnosis
Grant awards (39)
Development of an Efficient 18F labeling technology based on tetrazine trans-cyclooctene ligation$616,880
R01 · FY2025 · CA · contact PI
Development of an Efficient 18F labeling technology based on tetrazine trans-cyclooctene ligation$643,360
R01 · FY2024 · CA · contact PI
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$503,511
R01 · FY2024 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots$474,089
R01 · FY2024 · CA · contact PI
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$525,898
R01 · FY2023 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots$489,318
R01 · FY2023 · CA · contact PI
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds$458,297
R01 · FY2023 · EB · contact PI
Development of IDO PET agents for immunotherapy$396,007
R01 · FY2023 · CA · contact PI
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$531,155
R01 · FY2022 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots$489,570
R01 · FY2022 · CA · contact PI
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds$458,297
R01 · FY2022 · EB · contact PI
Development of IDO PET agents for immunotherapy$396,007
R01 · FY2022 · CA · contact PI
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$552,591
R01 · FY2021 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots$507,058
R01 · FY2021 · CA · contact PI
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds$449,131
R01 · FY2021 · EB · contact PI
Development of IDO PET agents for immunotherapy$404,087
R01 · FY2021 · CA · contact PI
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds Supplement$386,477
R01 · FY2021 · EB · contact PI
The development of novel radiation-sensitizer based on ultra-small carbon dots$526,148
R01 · FY2020 · CA · contact PI
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds$467,297
R01 · FY2020 · EB · contact PI
Development of IDO PET agents for immunotherapy$404,087
R01 · FY2020 · CA · contact PI
Translational Cancer Imaging$161,984
P30 · FY2020 · CA · contact PI
Development of IDO PET agents for immunotherapy$404,087
R01 · FY2019 · CA · contact PI
Translational Cancer Imaging$157,012
P30 · FY2019 · CA · contact PI
Small Animal Imaging Core$52,476
U54 · FY2019 · CA · contact PI
Translational Cancer Imaging$161,985
P30 · FY2018 · CA · contact PI
Small Animal Imaging Core$62,559
U54 · FY2018 · CA · contact PI
Translational Cancer Imaging$2,968
P30 · FY2018 · CA · contact PI
Translational Cancer Imaging$2,102
P30 · FY2018 · CA · contact PI
Translational Cancer Imaging$1,367
P30 · FY2018 · CA · contact PI
Small Animal PET/CT for Preclinical Imaging Research$834,500
S10 · FY2017 · OD · contact PI
Translational Cancer Imaging$158,912
P30 · FY2017 · CA · contact PI
Small Animal Imaging Core$114,659
U54 · FY2017 · CA · contact PI
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer$330,463
R01 · FY2016 · EB · contact PI
Translational Cancer Imaging$159,864
P30 · FY2016 · CA · contact PI
Small Animal Imaging Core$69,482
U54 · FY2016 · CA · contact PI
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer$323,853
R01 · FY2015 · EB · contact PI
Small Animal Imaging Core$62,559
U54 · FY2015 · CA · contact PI
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer$346,592
R01 · FY2014 · EB · contact PI
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radioth$373,631
R01 · FY2013 · EB · contact PI